Bleselumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | CD40 |
| Clinical data | |
| Other names | ASKP1240 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6412H9906N1690O2018S38 |
| Molar mass | 144175.87 g·mol−1 |
Bleselumab (INN; development code ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.
This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.